Skip to content

Clinical trials

Colonic Neoplasms trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colonic Neoplasms Phase: Not applicable Country / region: United States Clear all

255 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20022
20032
20045
200510
20069
200710
20086
20099
201010
20119
201211
201314
201413
20159
20169
201713
201814
201911
20208
202119
202215
20239
202411
20257
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed162
Recruiting24
Terminated22
Active, not recruiting16
Unknown status12
Withdrawn12
Enrolling by invitation4
Suspended2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Indiana University9
Fox Chase Cancer Center8
Ohio State University Comprehensive Cancer Center8
University of California, San Francisco8
University of Pennsylvania7
Massachusetts General Hospital6
Roswell Park Cancer Institute6
Stanford University6
Washington University School of Medicine6
City of Hope Medical Center5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colonic Neoplasms255
Rectal Neoplasms97
Colorectal Neoplasms75
Breast Neoplasms46
Lung Neoplasms32
Neoplasms27
Pancreatic Neoplasms25
Prostatic Neoplasms23
Ovarian Neoplasms21
Stomach Neoplasms18

Trials

Showing 1 to 25 of 255. Each trial links to its page on Pharma Observatory.

155 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.